EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: person:"Fossett, Sarah J."
Narrow search

Narrow search

Year of publication
Subject
All
CEO compensation 2 Research & Development 2 drug development 2 employee effect 2 prescription drugs 2 price earnings ratio 2 profitability 2 Arzneimittel 1 Gesundheitskosten 1 Health care costs 1 Pharmaceutical industry 1 Pharmaceuticals 1 Pharmacology 1 Pharmaindustrie 1 Pharmakologie 1
more ... less ...
Online availability
All
Free 2
Type of publication
All
Book / Working Paper 2
Type of publication (narrower categories)
All
Working Paper 2 Arbeitspapier 1 Graue Literatur 1 Non-commercial literature 1
Language
All
English 2
Author
All
Fossett, Sarah J. 2 Wunnava, Phanindra V. 2
Published in...
All
Discussion paper series / IZA 1 IZA Discussion Papers 1
Source
All
ECONIS (ZBW) 1 EconStor 1
Showing 1 - 2 of 2
Cover Image
Active Ingredients: Exploring the Key Factors Affecting the Rising Cost of Developing New Drugs
Fossett, Sarah J.; Wunnava, Phanindra V. - 2017
What makes prescription drugs cost so much? The media and Congress say it is corporate greed, while pharmaceutical firms blame federal regulations and an expensive drug development process. This study focuses on R & D (R&D) expenditures at global pharmaceutical firms and explores the driving...
Persistent link: https://www.econbiz.de/10011744529
Saved in:
Cover Image
Active ingredients : exploring the key factors affecting the rising cost of developing new drugs
Fossett, Sarah J.; Wunnava, Phanindra V. - 2017
What makes prescription drugs cost so much? The media and Congress say it is corporate greed, while pharmaceutical firms blame federal regulations and an expensive drug development process. This study focuses on R & D (R&D) expenditures at global pharmaceutical firms and explores the driving...
Persistent link: https://www.econbiz.de/10011670851
Saved in:
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...